Foundation Pharma & Biotech Education The foundation behind the Training Course on Quality Management in Pharma and Biotech Foundation Pharma & Biotech Education In 1987, the Foundation “Biotechnology Studies Delft Leiden” (BSDL Foundation) was established as a collaborative initiative between Delft University of Technology and Leiden University. The foundation is located in Delft within the Biotechnology Department and is a part of the research school “Biotechnology Sciences Delft Leiden” (BSDL Research School), which also includes Wageningen University.The BSDL Foundation was initially established with a startup grant from the Ministry of Education and a subsidy from the European Social Fund (ESF). In consultation with the business community, these funds were used to set up two-year postgraduate programs for training biotechnology R&D specialists and design specialists for the industry and environmental sector. Additionally, short international courses (“Advanced Courses”) were developed on various areas of biotechnology and quality management for participants from industry, institutes, universities, and hospitals.In 1997/1998, the “Training Course on Quality Management in Pharma and Biotech” (Q-course) was established in response to industry demand (including Centocor) and through the involvement of Professor Rob Verpoorte, who was a board member representing Leiden University at the BSDL Foundation at that time. Initially, the BSDL Foundation requested the Leiden Academic Centre for Drug Research (LACDR) to establish the course as it would be a better fit there than in Delft, but this was not possible at the time. Therefore, the BSDL Foundation eventually took on the responsibility.In 1997/1998, the Q-course consisted of 8 modules, but this was considered excessive. From 2000/2001, 6 modules were offered, 5 modules in 2002/2003, and 4 modules from 2004 onwards.The Foundation Pharma & Biotech Education oversees the development of the Q-Course modules. Quality Management in Pharma and Biotech courses The quality management in pharma and biotech educational program consists of four separate modules;Module 1 – the Role of the Qualified Person,Module 2 – Quality Management in Drug Development,Module 3 – Quality Management in Sterile Manufacturing,Module 4 – Quality Management in Manufacturing of Biopharmaceuticals.All modules can be purchased at once, offering participants a discount. The combined training is called: Quality Management in Pharma and Biotech. Quality Management in Pharma and Biotech Four modules offering an integrated approach to quality management in pharma and biotech, and in hospitals, to safeguard the quality of their products. 13 days in total Intermediate level 4 rating based on 1977 ratings. Language(s): € 8.550 ex. VAT More Information Quality Management in Manufacturing of Biopharmaceuticals Three days on manufacturing biopharmaceuticals & quality aspects 3 days in total Intermediate level 4 rating based on 560 ratings. Language(s): Next edition: 21-11-2023 € 2.590 ex. VAT More Information Quality Management in Sterile Manufacturing Training on sterility assurance challenges in the pharmaceutical industry and hospital pharmacies. Including new Annex 1 and Contamination Control. 3 days in total Intermediate level 4 rating based on 455 ratings. Language(s): Next edition: 31-10-2023 € 2.590 ex. VAT More Information Quality Management - The Role of the Qualified Person Quality Management - exploring the role of the Qualified Person 5 days in total Intermediate level 4.5 rating based on 617 ratings. Language(s): Next edition: 09-04-2024 € 3.225 ex. VAT More Information Quality Management in Drug Development This two-day training provides insight into the regulatory requirements for drug development from both the viewpoint of regulatory authorities as well as inspection bodies. 2 days in total Intermediate level Language(s): Next edition: 27-09-2023 € 2.280 ex. VAT More Information